New and improved tools

Sixteenth Programme Report

The new or improved tools (area B of the TDR strategy) described below include not only drugs, vaccines and diagnostic procedures, but also products such as recommendations on regulatory procedures that govern the introduction of new drugs. During the biennium, TDR’s activities in the diagnostics area increased, with a major emphasis on tuberculosis (TB). TDR’s vaccine-related activities were focused on malaria and leishmaniasis.

Among the important steps forward during the biennium were: registration of a new drug treatment for visceral leishmaniasis; progress towards registration of a new antimalarial formulation and a new antimalarial drug; impending entry into clinical trials of new recombinant vaccine candidates for malaria and leishmaniasis; and development of infrastructure to support laboratory and field testing of diagnostic kits for TB and some sexually transmitted diseases.

Related document